Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

7. Property and Equipment

7. Property and Equipment

12 Months Ended

Mar. 31, 2014

Property, Plant and Equipment [Abstract]

Property and equipment consists of the following:

	March 31,
	2014			2013
Manufacturing, lab, and other equipment	$	3,073,000		$	2,731,000
Office equipment		302,000			356,000
Furniture and fixtures		88,000			78,000
Leasehold improvements		269,000			282,000
		3,732,000			3,447,000
Less: accumulated depreciation and amortization		(2,761,000	)		(2,647,000	)
	$	971,000		$	800,000

Depreciation and amortization expense amounted to $284,000 and $268,000 for the years ended March 31, 2014 and 2013, respectively.

During the year ended March 31, 2014 and 2013, the Company incurred losses on the disposal of property and equipment in the amounts of $39,000 and $2,000, respectively. This amount was recorded within operating expenses in the accompanying consolidated statements of comprehensive income (loss).

- Definition

The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details